IBDEI1EH ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23796,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23796,1,2,0)
 ;;=2^90837
 ;;^UTILITY(U,$J,358.3,23796,1,3,0)
 ;;=3^PSYTX PT/FAM 53-89 MIN
 ;;^UTILITY(U,$J,358.3,23797,0)
 ;;=90785^^88^1009^1^^^^1
 ;;^UTILITY(U,$J,358.3,23797,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23797,1,2,0)
 ;;=2^90785
 ;;^UTILITY(U,$J,358.3,23797,1,3,0)
 ;;=3^PSYTX INTERACTIVE COMPLEXITY
 ;;^UTILITY(U,$J,358.3,23798,0)
 ;;=90833^^88^1010^1^^^^1
 ;;^UTILITY(U,$J,358.3,23798,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23798,1,2,0)
 ;;=2^90833
 ;;^UTILITY(U,$J,358.3,23798,1,3,0)
 ;;=3^PSYTX PT/FAM 16-37 MIN-REPORT W/ E&M CODE
 ;;^UTILITY(U,$J,358.3,23799,0)
 ;;=90836^^88^1010^2^^^^1
 ;;^UTILITY(U,$J,358.3,23799,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23799,1,2,0)
 ;;=2^90836
 ;;^UTILITY(U,$J,358.3,23799,1,3,0)
 ;;=3^PSYTX PT/FAM 38-52 MIN-REPORT W/ E&M CODE
 ;;^UTILITY(U,$J,358.3,23800,0)
 ;;=90838^^88^1010^3^^^^1
 ;;^UTILITY(U,$J,358.3,23800,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23800,1,2,0)
 ;;=2^90838
 ;;^UTILITY(U,$J,358.3,23800,1,3,0)
 ;;=3^PSYTX PT/FAM 53-89 MIN-REPORT W/ E&M CODE
 ;;^UTILITY(U,$J,358.3,23801,0)
 ;;=90839^^88^1011^1^^^^1
 ;;^UTILITY(U,$J,358.3,23801,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23801,1,2,0)
 ;;=2^90839
 ;;^UTILITY(U,$J,358.3,23801,1,3,0)
 ;;=3^PSYTX CRISIS INITIAL 30-74 MIN
 ;;^UTILITY(U,$J,358.3,23802,0)
 ;;=90840^^88^1011^2^^^^1
 ;;^UTILITY(U,$J,358.3,23802,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23802,1,2,0)
 ;;=2^90840
 ;;^UTILITY(U,$J,358.3,23802,1,3,0)
 ;;=3^PSYTX CRISIS EA ADDL 30 MIN
 ;;^UTILITY(U,$J,358.3,23803,0)
 ;;=99354^^88^1012^3^^^^1
 ;;^UTILITY(U,$J,358.3,23803,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23803,1,2,0)
 ;;=2^99354
 ;;^UTILITY(U,$J,358.3,23803,1,3,0)
 ;;=3^PROLONGED SVC,OTPT,1ST HR
 ;;^UTILITY(U,$J,358.3,23804,0)
 ;;=99355^^88^1012^4^^^^1
 ;;^UTILITY(U,$J,358.3,23804,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23804,1,2,0)
 ;;=2^99355
 ;;^UTILITY(U,$J,358.3,23804,1,3,0)
 ;;=3^PROLONGED SVC,OTPT,EA ADDL 30MIN
 ;;^UTILITY(U,$J,358.3,23805,0)
 ;;=99356^^88^1012^1^^^^1
 ;;^UTILITY(U,$J,358.3,23805,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23805,1,2,0)
 ;;=2^99356
 ;;^UTILITY(U,$J,358.3,23805,1,3,0)
 ;;=3^PROLONGED SVC,INPT/OBS,1ST HR
 ;;^UTILITY(U,$J,358.3,23806,0)
 ;;=99357^^88^1012^2^^^^1
 ;;^UTILITY(U,$J,358.3,23806,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23806,1,2,0)
 ;;=2^99357
 ;;^UTILITY(U,$J,358.3,23806,1,3,0)
 ;;=3^PROLONGED SVC,INPT/OBS,EA ADDL 30MIN
 ;;^UTILITY(U,$J,358.3,23807,0)
 ;;=90656^^88^1013^2^^^^1
 ;;^UTILITY(U,$J,358.3,23807,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23807,1,2,0)
 ;;=2^90656
 ;;^UTILITY(U,$J,358.3,23807,1,3,0)
 ;;=3^FLU VACCINE,NO PRESERVATIVES IM
 ;;^UTILITY(U,$J,358.3,23808,0)
 ;;=90658^^88^1013^1^^^^1
 ;;^UTILITY(U,$J,358.3,23808,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23808,1,2,0)
 ;;=2^90658
 ;;^UTILITY(U,$J,358.3,23808,1,3,0)
 ;;=3^FLU VACCINE IM
 ;;^UTILITY(U,$J,358.3,23809,0)
 ;;=90471^^88^1013^6^^^^1
 ;;^UTILITY(U,$J,358.3,23809,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23809,1,2,0)
 ;;=2^90471
 ;;^UTILITY(U,$J,358.3,23809,1,3,0)
 ;;=3^IMMUNIZATION ADMIN,IM
 ;;^UTILITY(U,$J,358.3,23810,0)
 ;;=J2680^^88^1013^3^^^^1
 ;;^UTILITY(U,$J,358.3,23810,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23810,1,2,0)
 ;;=2^J2680
 ;;^UTILITY(U,$J,358.3,23810,1,3,0)
 ;;=3^FLUPHENAZINE DECANOATE Up To 25 MG
 ;;^UTILITY(U,$J,358.3,23811,0)
 ;;=J1631^^88^1013^4^^^^1
 ;;^UTILITY(U,$J,358.3,23811,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23811,1,2,0)
 ;;=2^J1631
